TipRanks
Go Ultimate55% OFF

OrbusNeich Medical Group Holdings Limited (6929) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

6929 Analyst Ratings

Moderate Buy
1Ratings
1Buy0Hold0Sell
Based on 1 analysts giving stock ratings to OrbusNeich Medical Group Holdings Limited in the past 3 months

6929 Stock 12 Month Forecast

HKD 5.30▲(41.90% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for OrbusNeich Medical Group Holdings Limited in the last 3 months. The average price target is HKD 5.30 with a high forecast of HKD 5.30 and a low forecast of HKD 5.30. The average price target represents a 41.90% change from the last price of HKD 3.73.
Highest Price TargetHKD 5.30Average Price TargetHKD 5.30Lowest Price TargetHKD 5.30

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for HK:6929
Price TargetFollowArticle
CICC Analyst forecast on HK:6929Unknown AnalystNot RankedCICCHKD 5.30buy41.90%UpsideReiterated08/14/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ORKAOruka Therapeutics
ACHVAchieve Life Sciences
OVIDOvid Therapeutics
ZYMEZymeworks
CELCCelcuity

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering OrbusNeich Medical Group Holdings Limited

3 Months
OpenAI Health Care HK
OpenAI Health Care HKTipRanks - OpenAI
Success Rate3/4 ratings generated profit
75%
Average Return
+5.63%

Copying OpenAI Health Care HK's trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +5.63% per trade.

1 Year
OpenAI Health Care HK
OpenAI Health Care HKTipRanks - OpenAI
Success Rate3/4 ratings generated profit
75%
Average Return
+7.20%

Copying OpenAI Health Care HK's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +7.20% per trade.

2 Years
OpenAI Health Care HK
OpenAI Health Care HKTipRanks - OpenAI
Success Rate3/4 ratings generated profit
75%
Average Return
+7.20%

Copying OpenAI Health Care HK's trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +7.20% per trade.

6929 Analyst Recommendation Trends

00.511.52Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for 6929
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy00000
Buy00111
Hold00000
Sell00000
Strong Sell00000
total00111

In the current month, 6929 has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 6929 average Analyst price target in the past 3 months is 5.30.

6929 Financial Forecast

HKD -1HKD -0.5HKD 0HKD 0.5HKD 1Q2 2025Q2 2026Q4 2026
ConsensusHKD 0.20

6929 Earnings Forecast

Next quarter’s earnings estimate for 6929 is HKD 0.20 with a range of ― to ―. The previous quarter’s EPS was HKD 0.20. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

HKD 651.1MHKD 700MHKD 749MHKD 798MHKD 846.9MQ2 2025Q2 2026Q4 2026
HighHKD 847M
ConsensusHKD 847M
LowHKD 847M

6929 Sales Forecast

Next quarter’s sales forecast for 6929 is HKD 846.91M with a range of HKD 846.91M to HKD 846.91M. The previous quarter’s sales results were HKD 772.31M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

6929 Stock Forecast FAQ

What is HK:6929’s average 12-month price target, according to analysts?
Based on analyst ratings, OrbusNeich Medical Group Holdings Limited’s 12-month average price target is HK$5.30.
What is HK:6929’s upside potential, based on the analysts’ average price target?
OrbusNeich Medical Group Holdings Limited has 41.90% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is OrbusNeich Medical Group Holdings Limited a Buy, Sell or Hold?
OrbusNeich Medical Group Holdings Limited has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is OrbusNeich Medical Group Holdings Limited’s share price target?
The average share price target for OrbusNeich Medical Group Holdings Limited is HK$5.30. This is based on 1 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is HK$5.30, and the lowest forecast is HK$5.30. The average share price target represents a 41.90% increase from the current price of HK$3.735.
What do analysts say about OrbusNeich Medical Group Holdings Limited?
OrbusNeich Medical Group Holdings Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of OrbusNeich Medical Group Holdings Limited?
To buy shares of HK:6929, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.